Page 115 - 2019_08-Haematologica-web

RUNX1 transactivated and interacted with KLF4
References
1. Ichikawa M, Yoshimi A, Nakagawa M, Nishimoto N, Watanabe-Okochi N, Kurokawa M. A role for RUNX1 in hematopoiesis and myeloid leukemia. Int J Hematol. 2013;97(6):726-734.
2. Warren AJ, Bravo J, Williams RL, Rabbitts TH. Structural basis for the heterodimeric interaction between the acute leukaemia- associated transcription factors AML1 and CBFbeta. Embo J. 2000;19(12):3004-3015.
3. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with differ- ent regions of AML1. Mol Cell Biol. 1998;18(7):3915-3925.
4. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood. 2003;101(11):4333-4341.
5. Libermann TA, Pan Z, Akbarali Y, et al. AML1 (CBFalpha2) cooperates with B cell- specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem. 1999;274(35): 24671-24676.
6. Kim WY, Sieweke M, Ogawa E, et al. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. Embo J. 1999; 18(6):1609-1620.
7. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell. 1997;89(3):349-356.
8. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 1997;89(3): 341-347.
9. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N- CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A. 1998;95(18):10860-10865.
10. Lam K, Zhang DE. RUNX1 and RUNX1- ETO: roles in hematopoiesis and leukemo- genesis. Front Biosci (Landmark Ed).
2012;17:1120-1139.
11. Wang J, Saunthararajah Y, Redner RL, Liu
JM. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res. 1999;59(12):2766-2769.
12. Liu J, Xing H, Chen Y, et al. PIG7, transacti- vated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1-ETO fusion gene. Leukemia. 2012;26(1):117-126.
13. Huang Y, Chen J, Lu C, et al. HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation. Cell Death Dis. 2014;5:e1491.
14. Li W, Jiang Z, Li T, et al. Genome-wide analyses identify KLF4 as an important neg- ative regulator in T-cell acute lymphoblas- tic leukemia through directly inhibiting T- cell associated genes. Mol Cancer. 2015;14:26.
15. Morris VA, Cummings CL, Korb B, Boaglio S, Oehler VG. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets. Mol Cell Biol. 2016;36(4):559-573.
16. Liu S, Lu W, Li S, et al. Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells. Oncotarget. 2017;8(19):31901-31914.
17. Ogawa S, Satake M, Ikuta K. Physical and functional interactions between STAT5 and Runx transcription factors. J Biochem. 2008;143(5):695-709.
21. Nishimoto N, Arai S, Ichikawa M, et al. Loss of AML1/Runx1 accelerates the devel- opment of MLL-ENL leukemia through down-regulation of p19ARF. Blood. 2011;118(9):2541-2550.
22. Li X, Vradii D, Gutierrez S, et al. Subnuclear targeting of Runx1 is required for synergis- tic activation of the myeloid specific M- CSF receptor promoter by PU.1. J Cell Biochem. 2005;96(4):795-809.
23. Kohrs N, Kolodziej S, Kuvardina ON, et al. MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO. PLoS Genet. 2016;12(3):e1005946.
24. Feinberg MW, Wara AK, Cao Z, et al. The Kruppel-like factor KLF4 is a critical regula- tor of monocyte differentiation. Embo J. 2007;26(18):4138-4148.
25. Buchert M, Darido C, Lagerqvist E, et al. The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repres- sion of AML1/Runx1. Gastroenterology. 2009;137(1):156-164, 164.e1-3.
26. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression pro- files in acute myeloid leukemia. N Engl J Med. 2004;350(16):1617-1628.
27. Stirewalt DL, Meshinchi S, Kopecky KJ, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer. 2008;47(1):8-20.
28. Filarsky K, Garding A, Becker N, et al. Kruppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH sig- naling. Haematologica. 2016;101(6):e249-
18. Choi D, Park E, Jung E, et al. ORAI1
Activates Proliferation of Lymphatic
Endothelial Cells in Response to Laminar 253.
Flow Through Kruppel-Like Factors 2 and
4. Circ Res. 2017;120(9):1426-1439.
19. Ky N, Lim CB, Li J, Tam JP, Hamza MS, Zhao Y. KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57(Kip2). Apoptosis.
2009;14(9):1095-1107.
20. Ter Elst A, Ma B, Scherpen FJ, et al.
Repression of vascular endothelial growth factor expression by the runt-related tran- scription factor 1 in acute myeloid leukemia. Cancer Res. 2011;71(7):2761- 2771.
29. Yasunaga J, Taniguchi Y, Nosaka K, et al. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 2004;64(17):6002- 6009.
30. Gu X, Hu Z, Ebrahem Q, et al. Runx1 reg- ulation of Pu.1 corepressor/coactivator exchange identifies specific molecular tar- gets for leukemia differentiation therapy. J Biol Chem. 2014;289(21):14881-14895.
haematologica | 2019; 104(8)
1607